Blog

Sharesight20ASX top 20 ASX trades - 8th October 2019

by David Olsen, Senior Marketing Manager — Content/SEO, Sharesight | Oct 7th 2019
Disclaimer: The below article is for informational purposes only and does not constitute a product recommendation, or taxation or financial advice and should not be relied upon as such. Please check with your adviser or accountant to obtain the correct advice for your situation.

We're a day later with this week's update due to the public holiday in Australia Monday this week.

Last week Sharesight users jumped on medical small cap Actinogen Medical (ASX: ACW) after the company announced positive study results for their Alzheimer’s drug Xanamem. Some users also sold down Nufarm limited to realise some gains after the stock shot up 42% in the last week of September.

Top 20 ASX trades last week

Click for the full Sharesight20ASX:

Top20 ASX trades October 1st 2019)

Subscribe to Sharesight20 snapshots

Did you know you can receive Sharesight20 trading snapshots by email automatically? Subscribe here to always get the latest data when it's released.

Track your investment portfolio with Sharesight

Get access to Sharesight20 insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you:

Sign up for a FREE Sharesight account and get started tracking your investments today.

FURTHER READING

Tax loss selling

Tax loss selling for Australian investors

by Stephanie Stefanovic | Apr 30th 2026

A tax loss selling strategy can offset some of the capital gains you incurred during the year. Sharesight's unrealised CGT report can help.

EOFY checklist for investors

EOFY checklist for Australian investors

by Stephanie Stefanovic | Apr 30th 2026

Are you missing an EOFY opportunity? There’s still time to assess your investment portfolio and take advantage of the time left before 30 June.

Product updates Sharesight

Sharesight product updates – April 2026

by Milly Brent, Business Analyst at Sharesight | Apr 16th 2026

This month's focus was on expanding US bond coverage, adding Apple/Google Pay, launching a rebuilt Australian CGT report and simplifying dividend recording.